Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Scientific Reports|February 16, 2019
LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cellsMasato Miyoshi, Sei Kakinuma, Akihide Kamiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2019
Association of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agentsEmi Inoue-Shinomiya, Miyako Murakawa, Yasuhiro Asahina, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2023
Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitorsShun Kaneko, Yasuhiro Asahina, Mina Nakagawa, et al.
Journal of Gastroenterology|August 10, 2020
Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAsMina Nakagawa, Nobutoshi Nawa, Eiko Takeichi, et al.
Scientific Reports|April 7, 2019
Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patientsSayuri Nitta, Yasuhiro Asahina, Takanobu Kato, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2024
A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1-JNK pathway-dependent chemokinesKeiya Watakabe, Masato Miyoshi, Sei Kakinuma, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 17, 2024
Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived ModelJun Tsuchiya, Masato Miyoshi, Sei Kakinuma, et al.
Plos One|March 7, 2024
Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decadesShun Kaneko, Yasuhiro Asahina, Miyako Murakawa, et al.
Pageof 3